Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Eton Pharmaceuticals, Inc. has signed a licensing agreement to successfully acquire the exclusive U.S. marketing rights for Hemangeol oral solution from Pierre Fabre Medicament Sas.

Eton Pharmaceuticals, Inc. has signed a licensing agreement to successfully acquire the exclusive U.S. marketing rights for Hemangeol oral solution from Pierre Fabre Medicament Sas.

老虎证券老虎证券2026/03/02 12:42
Show original
This transaction will further strengthen Eton's product portfolio in the U.S. pharmaceutical market.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Smart ring manufacturer Oura (OURA.US) IPO reportedly oversubscribed by about 4 times

According to market sources, the initial public offering (IPO) of smart ring manufacturer Oura in the US stock market has reportedly been oversubscribed by approximately four times.

智通财经•2026/09/26 03:46